Ingen Technologies Stock Today
Performance0 of 100
| Odds Of DistressLess than 47
|
Ingen Technologies has 47 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for Ingen Technologies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Ingen Technologies, Inc., a medical device manufacturing company, manufactures medical products for the respiratory industry in United States. Ingen Technologies, Inc. was founded in 1999 and is based in Riverside, California. INGEN TECHNOLOGIES operates under Medical Devices classification in the United States and is traded on PNK Exchange.. The company has 8 M outstanding shares. More on Ingen Technologies
Ingen Technologies cannot be verified against its exchange. It appears that Ingen Technologies is not available for investing at the moment. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshIngen Pink Sheet Highlights
| CEO Director | David Hanson |
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Ingen Technologies [IGNT] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.8 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ingen Technologies's market, we take the total number of its shares issued and multiply it by Ingen Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Ingen Technologies conducts business under Healthcare sector and is part of Medical Devices industry. The entity has 8 M outstanding shares.
Ingen Technologies currently holds about 336 in cash with 6.62 M of positive cash flow from operations.
Check Ingen Technologies Probability Of Bankruptcy
Ingen Stock Against Markets
Try Other Suggestions
Be your own money manager
Our tools can tell you how much better you can do entering a position in Ingen Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Additional Tools for Ingen Pink Sheet Analysis
When running Ingen Technologies' price analysis, check to measure Ingen Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ingen Technologies is operating at the current time. Most of Ingen Technologies' value examination focuses on studying past and present price action to predict the probability of Ingen Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ingen Technologies' price. Additionally, you may evaluate how the addition of Ingen Technologies to your portfolios can decrease your overall portfolio volatility.